FDX
43
3
MTB
67
2
ILMN
42
5
KEY
46
3
BBY
46
10
HSIC
56
5
URBN
56
14
TXT
55
3
SWK
64
5
YUM
47
3
DVN
21
3
EL
25
4
PSX
47
2
AN
58
4
TGT
22
2
EFX
38
2
GE
67
2
WU
32
2
MPC
44
-3
MRK
25
-2
FDX
43
3
MTB
67
2
ILMN
42
5
KEY
46
3
BBY
46
10
HSIC
56
5
URBN
56
14
TXT
55
3
SWK
64
5
YUM
47
3
DVN
21
3
EL
25
4
PSX
47
2
AN
58
4
TGT
22
2
EFX
38
2
GE
67
2
WU
32
2
MPC
44
-3
MRK
25
-2
Financhill
Back

Collegium Pharmaceutical Vs. Context Therapeutics Industry Stock Comparison

Sell
30

COLL
Collegium Pharmaceutical

Last Price:
29.92
Seasonality Move:
19.53%
Sell
10

CNTX
Context Therapeutics

Last Price:
1.39
Seasonality Move:
-30%
Sell
30
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy, Sell or Hold?

  • The current Collegium Pharmaceutical [COLL] share price is $29.96. The Score for COLL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
10
Context Therapeutics (CNTX) is a Sell

Is Context Therapeutics a Buy, Sell or Hold?

  • The current Context Therapeutics [CNTX] share price is $1.39. The Score for CNTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • CNTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

COLL Stock Price Chart

What is Collegium Pharmaceutical's stock price today?

  • The Collegium Pharmaceutical share price today is $29.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COLL is experiencing selling pressure, which indicates risk of future bearish movement.

CNTX Stock Price Chart

What is Context Therapeutics's stock price today?

  • The Context Therapeutics share price today is $1.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNTX is experiencing slight buying pressure.

COLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.75 Sell
Relative Strength Index (14 RSI): 33.15 Sell
Chaikin Money Flow: -262078 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.5 - 35.14) Sell
Bollinger Bands (100): (32.57 - 38.29) Sell

CNTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 23.23 Sell
Chaikin Money Flow: 392487 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.75 - 2.29) Sell
Bollinger Bands (100): (1.89 - 2.39) Sell

COLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.92 Buy
20-day SMA: 32.15 Sell
50-day SMA: 35.66 Sell
200-day SMA: 35.36 Sell
8-day EMA: 30.37 Sell
20-day EMA: 31.98 Sell
50-day EMA: 34.15 Sell
200-day EMA: 33.95 Sell

CNTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.7 Sell
20-day SMA: 1.98 Sell
50-day SMA: 2 Sell
200-day SMA: 1.83 Sell
8-day EMA: 1.66 Sell
20-day EMA: 1.86 Sell
50-day EMA: 2 Sell
200-day EMA: 1.85 Sell

Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.80 per share, and an increase next year of $0.42 per share.

Context Therapeutics Earnings Growth & CNTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.21 per share.

Collegium Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Context Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):